As of the latest SEC filings, CYTOKINETICS INC (CYTK) is held by 483 institutional funds. The largest fund shareholder is T. Rowe Price Capital Appreciation Fund (PACLX), holding an estimated $336,515,961.99 in market value, representing 0.51% of its portfolio.
Funds holding CYTOKINETICS INC (CYTK)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CYTK
- CIK:
- 0001061983
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.51% | $336,515,961.99 | 5,105,689 | Mar 31, 2026 | May 28, 2026 |
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.25% | $266,805,195.93 | 4,048,023 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $257,229,527.49 | 3,902,739 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.60% | $222,782,817.58 | 3,482,614 | Apr 30, 2026 | Jun 26, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.27% | $192,706,405.71 | 2,923,781 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.11% | $187,169,438.43 | 2,839,773 | Mar 31, 2026 | May 28, 2026 |
|
FOTEX
Fidelity OTC Portfolio
|
MF | Fidelity | 0.36% | $145,295,061.00 | 2,271,300 | Apr 30, 2026 | Jun 26, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.17% | $139,392,927.18 | 2,114,898 | Mar 31, 2026 | May 28, 2026 |
|
PAMCX
T. Rowe Price Mid-Cap Growth Fund, Inc.
|
MF | T. Rowe Price | 0.49% | $111,163,806.00 | 1,686,600 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.27% | $104,847,650.70 | 1,590,770 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.11% | $90,022,184.85 | 1,365,835 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.18% | $87,756,067.23 | 1,331,453 | Mar 31, 2026 | May 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.84% | $77,650,218.75 | 1,178,125 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.23% | $75,707,471.48 | 1,183,484 | Apr 30, 2026 | Jun 26, 2026 |
|
-
JNL/T. Rowe Price Capital Appreciation Fund
|
ETF | Independent / Boutique | 0.52% | $72,539,293.71 | 1,100,581 | Mar 31, 2026 | May 28, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.88% | $70,693,352.34 | 1,072,574 | Mar 31, 2026 | May 28, 2026 |
|
TCAF
T. Rowe Price Capital Appreciation Equity ETF
|
ETF | T. Rowe Price | 1.11% | $68,882,672.82 | 1,045,102 | Mar 31, 2026 | May 28, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.25% | $60,738,833.22 | 921,542 | Mar 31, 2026 | Jun 1, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.48% | $60,173,984.52 | 912,972 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.73% | $59,119,424.52 | 896,972 | Mar 31, 2026 | May 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.03% | $57,836,725.44 | 929,552 | Feb 28, 2026 | Apr 24, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.20% | $43,807,487.61 | 684,813 | Apr 30, 2026 | Jun 26, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.40% | $43,707,293.76 | 663,136 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.10% | $40,140,610.80 | 645,140 | Feb 28, 2026 | Apr 24, 2026 |
|
SPMD
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
|
ETF | State Street (SPDR) | 0.25% | $39,360,726.99 | 597,189 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)